
About Extrovis Private Limited
Data last updated:
Extrovis Private Limited is a foreign private limited company based in Hyderabad, Telangana, India, a subsidiary of Extrovis A G and recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 March 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24304TG2017FTC115706. Its GSTIN is 36AAECE5880H1ZF (Telangana).
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹14.4 Lakh. It is led by directors including Bezawada Venkata Prasad (Whole-Time Director) and Hanumantha Rao Kamma.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2023, the company reported a revenue of ₹62.96 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.74 Cr (net margin 2.8%) and EBITDA of ₹5.78 Cr (EBITDA margin 9.2%). Revenue has grown at a compounded annual rate (CAGR) of 67% over three years and 93% over five years.
The company has about 243 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Extrovis. As per MCA filings, the company has open charges of ₹42.04 Cr and satisfied charges of ₹46.76 Cr on record. The company has 3 deals on record (2 rights issues, 1 funding round), with disclosed funding of ₹2.96 Cr; the latest was in June 2021.
Extrovis Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0005986). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website extrovis.com.
Company details
Recognitions & Rankings of Extrovis
- Category
- Small (2022-23)
- Udyam number
- UDYAM-TS-20-0005986
Contact details
Extrovis Private Limited's registered office is in Hyderabad, Telangana. Its website is extrovis.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressH No. 5 – 5 – 35/102&103 Plot No 22&23 Sy No 379 380 & 381 Prashanth Nagar Ie Kukatpally, Balanagar, Hyderabad, Telangana, India – 500072
- IndustryPharma, Drug Formulation & Development, Pharma Contract R&D
To see the full contact details of Extrovis Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Extrovis operates one associated brand: Extrovis. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| extrovis.com |
Financials of Extrovis Private Limited
FY 2024 filings availableExtrovis Private Limited reported revenue of ₹62.96 Cr (up 197% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 93% over five years, including 197% growth in the latest year. EBITDA rose 186% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹62.96 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.78 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.74 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.2% | ||||
| Net Profit Margin | 2.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Extrovis Private Limited, buy the company report.
Board of directors of Extrovis Private Limited
Extrovis has 4 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hanumantha Rao Kamma | Director | 05 Jun 2021 | 5 Years 5 Months | Current |
| Prasada Rao Gollapudi | Director | 01 Aug 2019 | 7 Years 3 Months | Current |
| Bezawada Venkata Prasad | Whole-Time Director | 10 Oct 2022 | 4 Years 1 Months | Current |
| Srinivasan Keshav Pagadala | Additional Director | 27 Oct 2025 | 1 Years 0 Months | Current |
Auditor
Extrovis Private Limited is audited by J D P & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| J D P & CO | FY 2023 | 019550S |
Shareholding
The shareholding of Extrovis Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Extrovis Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Apr 2025 | 101111280 | Hdfc Bank Limited | ₹40.19 Lakh | Open | |
| 16 Jul 2024 | 100970264 | Hdfc Bank Limited | ₹29.15 Lakh | Open | |
| 14 Nov 2023 | 100829102 | Others | ₹7.5 Cr | Open | |
| 14 Nov 2023 | 100829100 | Others | ₹22.5 Cr | Open | |
| 04 Apr 2023 | 100732836 | Hdfc Bank Limited | ₹14.58 Lakh | Open |
To see the full charge records of Extrovis Private Limited, buy the company report.
Total charge records: 12 View all charges
Deals & funding
Extrovis Private Limited has 3 deals on record (2 rights issues, 1 funding round), with disclosed funding of ₹2.96 Cr; the latest was in June 2021.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2021 | Funding round | ₹2.96 Cr | Investors: Extrovis AG, Switzerland |
| Dec 2018 | Rights issue | ₹31.4 Lakh | Investors: Extrovis AG, Switzerland |
| Aug 2017 | Rights issue | ₹5 Lakh | Investors: Extrovis AG, Switzerland |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Extrovis Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Extrovis Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Extrovis Private Limited has a workforce of 243 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 243 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 |
To see the full employee and EPFO history of Extrovis Private Limited, buy the company report.
GST
Extrovis has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAECE5880H1ZF | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Extrovis Private Limited, buy the company report.
Recent activity
Extrovis Private Limited has 14 board changes on record since 2019: 4 appointments and 10 cessations. The latest: Srinivasan Keshav Pagadala was appointed as Additional Director on 27 Oct 2025.
24 earlier events are in the company report.
Frequently asked questions
Extrovis is an active foreign private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 March 2017 (9+ years old) and is registered under CIN U24304TG2017FTC115706.
Extrovis has 4 current directors:
- Bezawada Venkata Prasad - Whole-Time Director
- Hanumantha Rao Kamma - Director
- Prasada Rao Gollapudi - Director
- Srinivasan Keshav Pagadala - Additional Director
The latest financial statements of Extrovis on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Extrovis is 36AAECE5880H1ZF, registered in Telangana.
The CIN (Corporate Identification Number) of Extrovis is U24304TG2017FTC115706. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Extrovis was incorporated on 07 March 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.
Extrovis has 3 deals on record (2 rights issues, 1 funding round), with disclosed funding of ₹2.96 Cr; the latest was in June 2021.
Srinivasan Keshav Pagadala was appointed as Additional Director on 27 Oct 2025. Gottumukkula Angad Ramakrishna Rayappa Raju ceased to be Additional Director on 29 Sep 2023. Bezawada Venkata Prasad ceased to be Additional Director on 28 Mar 2023. Extrovis has 14 board changes on record in total.
Yes, Extrovis is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Extrovis is registered as a small enterprise under Udyam registration (number: UDYAM-TS-20-0005986).

